Evidence for association between the 5′ flank of the NOS1 gene and schizophrenia in the Chinese population

International Journal of Neuropsychopharmacology

Volumn 11, Issue 8, 2008, Pages 1063-1071

  Tang, Wei ^a,b,c   Huang, Ke ^a,b,c   Tang, Ruqi ^a,b   Zhou, Guoquan ^c   Fang, Chao ^a   Zhang, Jing ^a,b   Du, Lingzhen ^d   Feng, Guoying ^e   He, Lin ^b   Shi, Yongyong ^a,b,d  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^c The Bio X Center Hospital   (China)

^d SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^e SHANGHAI MENTAL HEALTH CENTER   (China)

Author keywords

Association; Case control studies; Chinese population; Nitric oxide; NOS1; Schizophrenia

Indexed keywords

ADULT; ARTICLE; CHINESE; CONTROLLED STUDY; DNA FLANKING REGION; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC RISK; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; NOS1 GENE; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

5' FLANKING REGION; ADULT; ALLELES; CASE-CONTROL STUDIES; CHINA; DNA; FEMALE; GENE FREQUENCY; GENETIC MARKERS; GENOTYPE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE I; SAMPLE SIZE; SCHIZOPHRENIA;

EID: 55549133304     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145708008924     Document Type: Article

References (40)

1. Abkevich V, Camp NJ, Hensel CH, Neff CD, Russell DL, Hughes DC, Plenk AM, Lowry MR, Richards RL, Carter C, et al. (2003). Predisposition locus for major depression at chromosome 12q22-12q23.2. American Journal of Human Genetics 73, 1271-1281.
2. Bailer U, Leisch F, Meszaros K, Lenzinger E, Willinger U, Strobl R, Gebhardt C, Gerhard E, Fuchs K, Sieghart W, et al. (2000). Genome scan for susceptibility loci for schizophrenia. Neuropsychobiology 42, 175-182.
3. Bailer U, Leisch F, Meszaros K, Lenzinger E, Willinger U, Strobl R, Heiden A, Gebhardt C, Doge E, Fuchs K, Sieghart W, et al. (2002). Genome scan for susceptibility loci for schizophrenia and bipolar disorder. Biological Psychiatry 52, 40-52.
4. Bird DC, Bujas-Bobanovic M, Robertson HA, Dursun SM (2001). Lack of phencyclidine-induced effects in mice with reduced neuronal nitric oxide synthase. Psychopharmacology (Berlin) 155, 299-309.
5. Black MD, Selk DE, Hitchcock JM, Wettstein JG, Sorensen SM (1999). On the effect of neonatal nitric oxide synthase inhibition in rats: a potential neurodevelopmental model of schizophrenia. Neuropharmacology 38, 1299-1306.
6. Brenman JE, Xia H, Chao DS, Black SM, Bredt DS (1997). Regulation of neuronal nitric oxide synthase through alternative transcripts. Developmental Neuroscience 19, 224-231.
7. Bros M, Boissel JP, Godtel-Armbrust U, Forstermann U (2006). Transcription of human neuronal nitric oxide synthase mRNAs derived from different first exons is partly controlled by exon 1-specific promoter sequences. Genomics 87, 463-473.
8. Brzustowicz LM, Hodgkinson KA, Chow EW, Honer WG, Bassett AS (2000). Location of a major susceptibility locus for familial schizophrenia on chromosome 1q21-q22. Science 288, 678-682.
9. Brzustowicz LM, Simone J, Mohseni P, Hayter JE, Hodgkinson KA, Chow EW, Bassett AS (2004). Linkage disequilibrium mapping of schizophrenia susceptibility to the CAPON region of chromosome 1q22. American Journal of Human Genetics 74, 1057-1063.
10. Bujas-Bobanovic M, Bird DC, Robertson HA, Dursun SM (2000a). Blockade of phencyclidine-induced effects by a nitric oxide donor. British Journal of Pharmacology 130, 1005-1012.
11. Bujas-Bobanovic M, Robertson HA, Dursun SM (2000b). Effects of nitric oxide synthase inhibitor N(G)-nitro-L-arginine methyl ester on phencyclidine-induced effects in rats. European Journal of Pharmacology 409, 57-65.
12. Buttenschon HN, Mors O, Ewald H, McQuillin A, Kalsi G, Lawrence J, Gurling H, Kruse TA (2004). No association between a neuronal nitric oxide synthase (NOS1) gene polymorphism on chromosome 12q24 and bipolar disorder. American Journal of Medical Genetics, B: Neuropsychiatric Genetics 124, 73-75.
13. Cassidy F, Zhao C, Badger J, Claffey E, Dobrin S, Roche S, McKeon P (2007). Genome-wide scan of bipolar disorder and investigation of population stratification effects on linkage: Support for susceptibility loci at 4q21, 7q36, 9p21, 12q24, 14q24, and 16p13. American Journal of Medical Genetics, B: Neuropsychiatric Genetics 144, 791-801.
14. Clinton SM, Meador-Woodruff JH (2004). Abnormalities of the NMDA receptor and associated intracellular molecules in the thalamus in schizophrenia and bipolar disorder. Neuropsychopharmacology 29, 1353-1362.
15. Curtis D, Kalsi G, Brynjolfsson J, McInnis M, O'Neill J, Smyth C, Moloney E, Murphy P, McQuillin A, Petursson H, Gurling H (2003). Genome scan of pedigrees multiply affected with bipolar disorder provides further support for the presence of a susceptibility locus on chromosome 12q23-q24, and suggests the presence of additional loci on 1p and 1q. Psychiatric Genetics 13, 77-84.
16. Degn B, Lundorf MD, Wang A, Vang M, Mors O, Kruse TA, Ewald H (2001). Further evidence for a bipolar risk gene on chromosome 12q24 suggested by investigation of haplotype sharing and allelic association in patients from the Faroe Islands. Molecular Psychiatry 6, 450-455.
17. DeLisi LE, Shaw SH, Crow TJ, Shields G, Smith AB, Larach VW, Wellman N, Loftus J, Nanthakumar B, Razi K, et al. (2002). A genome-wide scan for linkage to chromosomal regions in 382 sibling pairs with schizophrenia or schizoaffective disorder. American Journal of Psychiatry 159, 803-812.
18. Detera-Wadleigh SD (1999). Chromosomes 12 and 16 workshop. American Journal of Medical Genetics 88, 255-259.
19. Ewald H, Degn B, Mors O, Kruse TA (1998). Significant linkage between bipolar affective disorder and chromosome 12q24. Psychiatric Genetics 8, 131-140.
20. Ewald H, Flint T, Kruse TA, Mors O (2002). A genome-wide scan shows significant linkage between bipolar disorder and chromosome 12q24.3 and suggestive linkage to chromosomes 1p22-21 4p16, 6q14-22, 10q26 and 16p13.3. Molecular Psychiatry 7, 734-744.
21. Fallin MD, Lasseter VK, Avramopoulos D, Nicodemus KK, Wolyniec PS, McGrath JA, Steel G, Nestadt G, Liang KY, Huganir RL, et al. (2005). Bipolar I disorder and schizophrenia: a 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios. American Journal of Human Genetics 77, 918-936.
22. Fritzen S, Lauer M, Schmitt A, Topner T, Strobel A, Lesch KP, Reif A (2007). NO synthase-positive striatal interneurons are decreased in schizophrenia. European Neuropsychopharmacology 17, 595-599.
23. Garthwaite J, Garthwaite G, Palmer RM, Moncada S (1989). NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices. European Journal of Pharmacology 172, 413-416.
24. Herken H, Uz E, Ozyurt H, Akyol O (2001). Red blood cell nitric oxide levels in patients with schizophrenia. Schizophrenia Research 52, 289-290.
25. Klamer D, Engel JA, Svensson L (2004). The neuronal selective nitric oxide synthase inhibitor, Nomega-propyl-L-arginine, blocks the effects of phencyclidine on prepulse inhibition and locomotor activity in mice. European Journal of Pharmacology 503, 103-107.
26. Lauer M, Johannes S, Fritzen S, Senitz D, Riederer P, Reif A (2005). Morphological abnormalities in nitric-oxide-synthase-positive striatal interneurons of schizophrenic patients. Neuropsychobiology 52, 111-117.
27. Liou YJ, Tsai SJ, Hong CJ, Liao DL (2003). Association analysis for the CA repeat polymorphism of the neuronal nitric oxide synthase (NOS1) gene and schizophrenia. Schizophrenia Research 65, 57-59.
28. Liu X, He G, Wang X, Chen Q, Qian X, Lin W, Li D, Gu N, Feng G, He L (2004). Association of DAAO with schizophrenia in the Chinese population. Neuroscience Letters 369, 228-233.
29. Lorrain DS, Hull EM (1993). Nitric oxide increases dopamine and serotonin release in the medial preoptic area. Neuroreport 5, 87-89.
30. Maziade M, Roy MA, Chagnon YC, Cliche D, Fournier JP, Montgrain N, Dion C, Lavallee JC, Garneau Y, Gingras N, et al. (2005). Shared and specific susceptibility loci for schizophrenia and bipolar disorder: a dense genome scan in Eastern Quebec families. Molecular Psychiatry 10, 486-499.
31. Miranda A, Garcia J, Lopez C, Gordon D, Palacio C, Restrepo G, Ortiz J, Montoya G, Cardeno C, Calle J, et al. (2006). Putative association of the carboxy-terminal PDZ ligand of neuronal nitric oxide synthase gene (CAPON) with schizophrenia in a Colombian population. Schizophrenia Research 82, 283-285.
32. Morissette J, Villeneuve A, Bordeleau L, Rochette D, Laberge C, Gagne B, Laprise C, Bouchard G, Plante M, Gobeil L, et al. (1999). Genome-wide search for linkage of bipolar affective disorders in a very large pedigree derived from a homogeneous population in quebec points to a locus of major effect on chromosome 12q23-q24. American Journal of Medical Genetics 88, 567-587.
33. Reif A, Herterich S, Strobel A, Ehlis AC, Saur D, Jacob CP, Wienker T, Topner T, Fritzen S, Walter U, et al. (2006). A neuronal nitric oxide synthase (NOS-I) haplotype associated with schizophrenia modifies prefrontal cortex function. Molecular Psychiatry 11, 286-300.
34. Saha S, Chant D, Welham J, McGrath J (2005). A systematic review of the prevalence of schizophrenia. PLoS Medicine 2, e141.
35. Shink E, Harvey M, Tremblay M, Gagne B, Belleau P, Raymond C, Labbe M, Dube MP, Lafreniere RG, Barden N (2005). Analysis of microsatellite markers and single nucleotide polymorphisms in candidate genes for susceptibility to bipolar affective disorder in the chromosome 12Q24.31 region. American Journal of Medical Genetics, B: Neuropsychiatric Genetics 135, 50-58.
36. Shinkai T, Ohmori O, Hori H, Nakamura J (2002). Allelic association of the neuronal nitric oxide synthase (NOS1) gene with schizophrenia. Molecular Psychiatry 7, 560-563.
37. Yao JK, Leonard S, Reddy RD (2004). Increased nitric oxide radicals in postmortem brain from patients with schizophrenia. Schizophrenia Bulletin 30, 923-934.
38. Yilmaz N, Herken H, Cicek HK, Celik A, Yurekli M, Akyol O (2007). Increased levels of nitric oxide, cortisol and adrenomedullin in patients with chronic schizophrenia. Medical Principles and Practice 16, 137-141.
39. Yu, YW, Chen, TJ, Wang, YC, Liou, YJ, Hong, CJ, Tsai, SJ (2003). Association analysis for neuronal nitric oxide synthase gene polymorphism with major depression and fluoxetine response. Neuropsychobiology 47, 137-140.
40. Zheng Y, Li H, Qin W, Chen W, Duan Y, Xiao Y, Li C, Zhang J, Li X, Feng G, He L (2005). Association of the carboxylterminal PDZ ligand of neuronal nitric oxide synthase gene with schizophrenia in the Chinese Han population. Biochemical and Biophysical Research Communications 328, 809-815.